[Disseminated tuberculosis with splenic abscesses during haemodialysis].
B
B
Moragrega
R
R
Dolz
I
I
López Alejandre
A
A
Núñez Sánchez
D018784:Abdominal Abscess / Q000188:drug therapy / Q000209:etiology*; D000368:Aged; D000995:Antitubercular Agents / Q000627:therapeutic use; D001706:Biopsy; D003937:Diagnosis, Differential; D005188:False Negative Reactions; D019698:Hepatitis C, Chronic / Q000150:complications; D006801:Humans; D006973:Hypertension / Q000150:complications; D016867:Immunocompromised Host; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D007676:Kidney Failure, Chronic / Q000150:complications / Q000601:surgery / Q000628:therapy; D016030:Kidney Transplantation; D008198:Lymph Nodes / Q000382:microbiology / Q000473:pathology; D008297:Male; D009369:Neoplasms / Q000175:diagnosis; D009400:Nephrosclerosis / Q000150:complications; D011241:Prednisone / Q000009:adverse effects / Q000627:therapeutic use; D006435:Renal Dialysis; D013203:Staphylococcal Infections / Q000150:complications; D014391:Tuberculosis, Miliary / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D014400:Tuberculosis, Splenic / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy
D000995:Antitubercular Agents; D007166:Immunosuppressive Agents; D011241:Prednisone